Dita Estfarm SRL Pharmaceutical Import Profile — Moldova (DGFT 2022–2026)

Name: Dita Estfarm SRL Pharmaceutical Import Records from India — 2 Products, $277.1K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Dita Estfarm SRL — Pharmaceutical Importer Profile (2026) | 2 Products, $277.1K Trade | TransData Nexus

Dita Estfarm SRL

Pharmaceutical Importer · Moldova · Advanced Oncology Focus · $277.1K Total Trade · DGFT Verified

Dita Estfarm SRL is a pharmaceutical importer based in Moldova with a total trade value of $277.1K across 2 products in 1 therapeutic categories. Based on 6 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Dita Estfarm SRL sources from 17 verified Indian suppliers, with J B Chemicals And Pharmaceuticals Limited accounting for 26.1% of imports.

Dita Estfarm SRL — Import Portfolio & Supplier Network

Dita Estfarm SRL import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Dita Estfarm SRL?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
J B Chemicals And Pharmaceuticals Limited	$280.4K	12	26.1%
Naprod Life Sciences Private Limited	$133.0K	16	12.4%
Mylan Pharmaceuticals Private Limited

What Formulations Does Dita Estfarm SRL Import?

Formulation	Value	Ships
Bevacizumab csi 400MG/16ML 1 vl in	$100.0K	2
Jocet syrup 200 ML mol	$96.2K	2
Jocet syrup 100 ML mol	$76.3K	3
Rifampicin 150 MG and isoniazid 75 MG tablets bno. nrh2364b md.07/23 ed.06/26 ps: 24x28s	$54.7K	2
Heparin injection 25000iu/5ML,5ML	$50.0K	1
Heparin injection 25000 IU/5ML	$50.0K	1
Wencon 150 (fluconazole capsules 150 MG)	$50.0K	1
Epirubicin hydrochloride for injection 10MG (10000 vials)	$50.0K	1
Mgl gel tube 30 GM mol	$35.0K	2
Mgl gel tube 30 GM mol	$30.1K	3
Jocet syrup 200 ML mol exp	$28.3K	1
Brand verfen INJ fentanyl citrate usp50mcg ML 2ML ampoule bn en012352 en012353 md feb 2023 ed jan	$25.9K	1
Brand verket INJ ketamine hcl BP 50 MG ML 10 ML amps bn ex952301 md jan 2023 ed dec 2024 qty 21750	$24.9K	1
Harmless medicine for human consumptionbiphasic isophane insulin injection i.p100iu/ML 3ML batch no. nr7kr75 manufacturing	$23.0K	1
R-meth hcl oc 5MG 1000ML(cherry)enmd methadone oral concentrate solution 5MG/ML,1000ML(ps:n9)bno.25362401, 25362402	$20.4K	1

Dita Estfarm SRL imports 88 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Bevacizumab	Advanced Oncology	$200.0K	4	0.4%	12
2	Epirubicin	Advanced Oncology	$77.1K	2	1.2%	12

Dita Estfarm SRL imports 2 pharmaceutical products across 1 categories into Moldova totaling $277.1K.

Dita Estfarm SRL — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Dita Estfarm SRL is a leading pharmaceutical distributor based in Chișinău, Moldova, with over 30 years of experience in the import and distribution of pharmaceutical products. Established on June 29, 1995, the company has grown to become a pivotal player in Moldova's healthcare sector, serving over 1,200 pharmacies and 800 medical institutions nationwide. (dita.md)

The company operates a modern logistics center equipped with advanced technology, ensuring efficient and secure distribution of a diverse portfolio of over 8,000 products. Dita Estfarm SRL's mission is to provide rapid and efficient access to high-quality pharmaceutical products, positioning itself as the number one partner for medical institutions and pharmacies across Moldova. (dita.md)

2Distribution Network

Dita Estfarm SRL's distribution network is centralized in Chișinău, where it manages a state-of-the-art logistics center. This facility spans 7,000 square meters and utilizes semi-automated technology from KNAPP, featuring a 120-meter line with 11 collection stations and Pick-it-Easy technology. The center operates 24/7, with continuous temperature and humidity monitoring systems in place to ensure optimal storage conditions for pharmaceutical products. (dita.md)

The company maintains a fleet of 30 vehicles equipped with temperature and humidity control systems, facilitating daily deliveries to over 800 customers across Moldova. This infrastructure enables Dita Estfarm SRL to provide fast and secure distribution, ensuring the availability of essential health products nationwide. (dita.md)

3Industry Role

Dita Estfarm SRL plays a central role in Moldova's pharmaceutical supply chain as a primary wholesaler and distributor. By importing and distributing a wide range of pharmaceutical products, the company ensures that pharmacies, hospitals, and medical institutions have timely access to essential medications and health products. Its extensive distribution network and modern logistics capabilities position it as a key player in the Moldovan healthcare sector. (dita.md)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Dita Estfarm SRL

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Dita Estfarm SRL's sourcing strategy exhibits a high degree of concentration, with its top five products—Bevacizumab and Epirubicin—accounting for 100% of its imports from India. This indicates a focused approach to procurement, potentially leveraging volume discounts and streamlined logistics. However, such concentration may expose the company to supply chain risks if any of these products face production or regulatory issues.

The company's reliance on a limited number of suppliers from India, including J B Chemicals and Pharmaceuticals Limited, Naprod Life Sciences Private Limited, and Mylan Pharmaceuticals Private Limited, suggests established and stable relationships. The consistent shipment patterns and significant order volumes reflect a strategic choice to maintain strong partnerships with key suppliers. Nonetheless, diversifying the supplier base could mitigate potential risks associated with over-reliance on specific sources.

2Supply Chain Resilience

Dita Estfarm SRL's supply chain resilience is supported by its partnerships with multiple Indian suppliers, providing alternative sources for its key products. The company's import of 88 unique pharmaceutical formulations indicates a diversified product portfolio, reducing dependency on single-source products. Additionally, the modern logistics infrastructure, including the KNAPP semi-automated system and temperature-controlled storage, enhances the company's ability to manage and distribute products efficiently.

Importing Pharmaceuticals into Moldova — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Moldova

1Regulatory Authority & Framework

In Moldova, the National Agency for Medicines and Medical Devices (NAMMD) is the primary regulatory authority overseeing the import, registration, and distribution of pharmaceutical products. NAMMD ensures that all pharmaceutical products meet the required safety, efficacy, and quality standards before they are authorized for sale in the country.

Key legislation governing pharmaceutical imports includes the Law on Medicinal Products and the Law on Public Procurement. These laws establish the regulatory framework for the importation, registration, and distribution of pharmaceutical products, as well as the procedures for public procurement in the healthcare sector.

The marketing authorization pathway for Indian generics involves submitting a registration dossier to NAMMD, which includes comprehensive data on the product's quality, safety, and efficacy. Upon successful evaluation, NAMMD grants marketing authorization, allowing the product to be imported and distributed within Moldova.

2Import Licensing & GMP

Import licensing requirements in Moldova stipulate that all pharmaceutical products must be registered with NAMMD before importation. Importers must obtain an import license, which is contingent upon the product's registration status and compliance with Moldovan regulations.

Good Manufacturing Practice (GMP) certification is recognized in Moldova, with NAMMD accepting certifications from reputable authorities such as the European Medicines Agency (EMA), the World Health Organization (WHO), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Indian exporters seeking to supply Dita Estfarm SRL must ensure that their manufacturing facilities hold valid GMP certifications from these recognized bodies.

Dita Estfarm SRL — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Dita Estfarm SRL's focus on importing and distributing products within the Advanced Oncology therapeutic category aligns with the growing demand for cancer treatments in Moldova. The high import values of Bevacizumab and Epirubicin indicate a strategic emphasis on providing essential oncology medications to meet patient needs.

The market demand for these products is driven by the increasing prevalence of cancer and the need for effective treatment options. By concentrating on this therapeutic area, Dita Estfarm SRL positions itself as a specialized distributor, offering expertise and reliability in oncology pharmaceuticals.

2Sourcing Profile

Dita Estfarm SRL's sourcing strategy is centered on importing generic drugs from India, focusing on formulations that are in high demand within the oncology sector. This approach allows the company to provide cost-effective treatment options while ensuring access to essential medications.

India's well-established pharmaceutical industry, with its adherence to international quality standards and GMP certifications, makes it a preferred sourcing destination for Dita Estfarm SRL. The company's procurement strategy emphasizes reliability, quality, and compliance with Moldovan regulations.

3Market Positioning

Frequently Asked Questions — Dita Estfarm SRL

What products does Dita Estfarm SRL import from India?

Dita Estfarm SRL imports 2 pharmaceutical products across 1 categories. Top imports: Bevacizumab ($200.0K), Epirubicin ($77.1K).

Who supplies pharmaceuticals to Dita Estfarm SRL from India?

Dita Estfarm SRL sources from 17 verified Indian suppliers. The primary supplier is J B Chemicals And Pharmaceuticals Limited (26.1% of imports, $280.4K).

What is Dita Estfarm SRL's total pharmaceutical import value?

Dita Estfarm SRL's total pharmaceutical import value from India is $277.1K, based on 6 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Dita Estfarm SRL focus on?

Dita Estfarm SRL imports across 1 categories. The largest: Advanced Oncology (100.0%).

Get Full Dita Estfarm SRL Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.